High‑throughput sequencing to identify miRNA biomarkers in colorectal cancer patients

Sun,Yan; Wang,Lin; Guo,Sheng‑Chao; Wu,Xiao-Bing; Xu,Xue‑Hu

doi:10.3892/ol.2014.2215

High‑throughput sequencing to identify miRNA biomarkers in colorectal cancer patients

Authors:
- Yan Sun
- Lin Wang
- Sheng‑Chao Guo
- Xiao-Bing Wu
- Xue‑Hu Xu
View Affiliations

Affiliations: Department of Gastroenterology, The Third Affiliated Hospital of Guangzhou Medical University, Guangzhou, Guangdong 510150, P.R. China, Department of Oncology, Guangzhou Red Cross Hospital, Guangzhou, Guangdong 510150, P.R. China, Department of General Surgery, The Third Affiliated Hospital of Guangzhou Medical University, Guangzhou, Guangdong 510150, P.R. China
Published online on: June 3, 2014 https://doi.org/10.3892/ol.2014.2215
Pages: 711-713

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

The altered expression of microRNAs (miRNAs) is associated with a number of cancer types. The study of the association between the miRNA profile and cancer may be useful to identify potential biomarkers of certain types of cancer. In the present study, 19 miRNAs were identified by high‑throughput sequencing in the serum of colorectal cancer (CRC) patients. A network analysis was performed based on a computational approach to identify associations between CRC and miRNAs. The present study may be useful to identify cancer‑specific signatures and potentially useful biomarkers for the diagnosis of CRC. The network analysis of miRNA‑target genes may aid in identifying altered miRNA regulatory networks that are involved in tumor pathogenesis.

View Figures

View References

1	Tjandra JJ, Kilkenny JW, Buie WD, et al: Standards Practice Task Force; American Society of Colon and Rectal Surgeons: Practice parameters for the management of rectal cancer (revised). Dis Colon Rectum. 48:411–423. 2005.
2	Fearon ER: Molecular genetics of colorectal cancer. Annu Rev Pathol. 6:479–507. 2011.
3	Aaltonen LA, Peltomäki P, Leach FS, et al: Clues to the pathogenesis of familial colorectal cancer. Science. 260:812–816. 1993.
4	Bass AJ, Lawrence MS, Brace LE, et al: Genomic sequencing of colorectal adenocarcinomas identifies a recurrent VTI1A-TCF7L2 fusion. Nat Genet. 43:964–968. 2011.
5	Sjöblom T, Jones S, Wood LD, et al: The consensus coding sequences of human breast and colorectal cancers. Science. 314:268–274. 2006.
6	Wood LD, Parsons DW, Jones S, et al: The genomic landscapes of human breast and colorectal cancers. Science. 318:1108–1113. 2007.
7	Schepeler T, Reinert JT, Ostenfeld MS, et al: Diagnostic and prognostic microRNAs in stage II colon cancer. Cancer Res. 68:6416–6424. 2008.
8	Schetter AJ, Leung SY, Sohn JJ, et al: MicroRNA expression profiles associated with prognosis and therapeutic outcome in colon adenocarcinoma. JAMA. 299:425–436. 2008.
9	Lim LP, Glasner ME, Yekta S, Burge CB and Bartel DP: Vertebrate microRNA genes. Science. 299:15402003.
10	Zeng Y and Cullen BR: Sequence requirements for micro RNA processing and function in human cells. RNA. 9:112–123. 2003.
11	Ambros V: The functions of animal microRNAs. Nature. 431:350–355. 2004.
12	Kloosterman WP and Plasterk RH: The diverse functions of microRNAs in animal development and disease. Dev Cell. 11:441–450. 2006.
13	Perera RJ and Ray A: MicroRNAs in the search for understanding human diseases. BioDrugs. 21:97–104. 2007.
14	Iorio MV, Visone R, Di Leva G, et al: MicroRNA signatures in human ovarian cancer. Cancer Res. 67:8699–8707. 2007.
15	Caldas C and Brenton JD: Sizing up miRNAs as cancer genes. Nat Med. 11:712–714. 2005.
16	Jones KB, Salah Z, Del Mare S, et al: miRNA signatures associate with pathogenesis and progression of osteosarcoma. Cancer Res. 72:1865–1877. 2012.
17	Volinia S, Galasso M, Costinean S, et al: Reprogramming of miRNA networks in cancer and leukemia. Genome Res. 20:589–599. 2010.
18	Lu J, Getz G, Miska EA, et al: MicroRNA expression profiles classify human cancers. Nature. 435:834–838. 2005.
19	Luo X, Burwinkel B, Tao S and Brenner H: MicroRNA signatures: novel biomarker for colorectal cancer? Cancer Epidemiol Biomarkers Prev. 20:1272–1286. 2011.
20	Jeong HC, Kim EK, Lee JH, Lee JM, Yoo HN and Kim JK: Aberrant expression of let-7a miRNA in the blood of non-small cell lung cancer patients. Mol Med Rep. 4:383–387. 2011.